Methods of using extracts of shark cartilage

Details Methods of using extracts of shark cartilage Methods of using extracts of shark cartilage

1996-08-08

2000-02-22

Eisenschenk, Frank C.

Drug, bio-affecting and body treating compositions

Dermatitis

Psoriasis

514859, 514828, 424520, A61K 3512

Patent

active

060281189

ABSTRACT:
The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, anti-tumoral, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a homogenate of cartilage in an aqueous solution, this homogenate being separated in a solid fraction (SOLID EXTRACT) and a liquid fraction which was further fractionated to obtain a LIQUID EXTRACT having molecules of a molecular weight comprised between 0 to 500 kDa. The composition of the liquid extract has then been investigated by different ways. Further fractionation of this extract led to the preliminary characterization of some of its active components. Due to the multiplicity of biological activities of the total liquid extract, it can be used for treating numerous diseases or conditions such as those having components selected from the group consisting of tumor proliferation, angiogenesis, inflammation and collagenolysis. Several cosmetic applications based on the capacity of the liquid extract to improve skin barrier function are also under the scope of this invention. These extracts have no offensive effect on normal body functions. Therefore, these shark cartilage extracts have a very promising therapeutic value. The process for the obtention of cartilage extracts is simple and efficient. The unexpectedly valuable products obtained by this process are therefore an indication of a new and non-obvious process.

REFERENCES:
patent: 3478146 (1969-11-01), Balassa
patent: 4042457 (1977-08-01), Kuettner et al.
patent: 4243582 (1981-01-01), Spilburg et al.
patent: 4350682 (1982-09-01), Balassa
patent: 4356261 (1982-10-01), Kuettner
patent: 4473551 (1984-09-01), Schinitsky
patent: 4656137 (1987-04-01), Balassa
patent: 4746729 (1988-05-01), Kuettner et al.
patent: 4749522 (1988-06-01), Kamarei
patent: 4822607 (1989-04-01), Balassa
patent: 5075112 (1991-12-01), Lane
Arnett, F.C. et al. (1988). Arthritis & Rheumatism, 31: 315-324.
Chabot-Fletcher, M. et al. (1994). "Interleukin-8 Production is Regulated by Protein Kinase C in Human Keratinocytes". The Journal of Investigative Dermatology 103(4): 509-515.
Elias, P.M. (1993). J. Invest. Dermatol. 80: 044s-049s.
Folkman, J. and M. Klagsbrun (1987). "Angiogenic Factors". Science . 235: 442-446.
Grove, G.L. (1994) "Age-Related Differences in Healing of Superficial Skin wounds in Humans" In The effects of aging in oral mucosa and skin. Ed. Squier & Hill CRC Press, pp. 121-127.
Langer, R et al. (1976). "Isolation of a Cartilage Factor That Inhibits Tumor Neovascularisation". Science. 193: 70-72.
Lee, A. and R. Langer (1983). "Shark Cartilage Contains Inhibitors of Tumor Angiogenesis". Science. 221: 1185-1187.
Luer. C.A. (1986). "Inhibitors of Angiogenesis from Shark Cartilage". Fed. Proc. 45(4): 949, Abstract 4624.
Matsui, M.S. et al. (1992). "Protein Kinase C in Normal Human Epidermal Keratinocytes During Proliferation and Calcium-Induced Differenciation". J. Invest. Dermatol. 99: 565-571.
Medina, D. and K.B. DeOME (1969). "Response of Hyperplastic Alveolar Nodule Outgrowth-Line D1 to Mammary Tumor Virus, Nodule-Inducing Virus, and Prolonged . . . " J. Natl. Cancer Inst. 42: 303-310.
Medina, D. (1976). Mammary Tumorigenesis in Chemical Carcinogen-Treated Mice, VI. Tumor-Producing Capabilities of Mammary Dysplasias in BALB/cCrgl Mice. J. Natl. Cancer Inst. 57: 1185-1189.
Moses, M.A. and R. Langer (1991). "Inhibitors of Angiogenesis". Biotechnology 9:630-634.
Nickoloff, B.J. et al. (1994). "Aberrant Production of Interleukin-8 and Thrombospondin-1 Psoriastic Keratinocytes Mediates Angiogenesis". Am. J.Pathology 144(4): 820-828.
Oikawa, T. et al. (1990) "A novel angiogenic inhibitor derived from Japanese shark cartilage (I). Extraction and estimation of inhibitory activities toward tumor and embyronic angiogenesis". Cancer Letters 51: 181-186.
Oresago, C. et al. (1987). "Eye Area Problems Puffiness, Bags, Dark Circles and Crowsfeet" Cosmetics and Toiletries 102: 29-34.
Pinnagoda, J. et al. (1990). Guidelines for transepidermal water loss (TEWL) measurement Contact Dermatitis 22: 164-178.
Ritchie, D.M. et al. (1968). "Clinical Studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis". Quarterly J. Med. New Series XXXVII, 147: 393-406.
Suzuki, F. et al. (1984). "Cartilage-derived Antitumor Factor (CATF): A High Molecular Weight Fraction in Cartilage Extract Inhibits Solid Tumor Growth". J. of Bone and Mineral Metabolism 2(3): 3-7.
Weingarten, H. et al. (1985). "Synthetic Substrate of Vertebrate Collagenase". Biochemistry 24: 6730-6734.

Affiliated with

Also associated with

Rating

Methods of using extracts of shark cartilage does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of using extracts of shark cartilage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using extracts of shark cartilage will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-521027